Psychological Distress, Alexithymia and Alcohol Misuse in Patients with Psoriasis: A Cross-Sectional Study

Adamzik, K., McAleer, M. A., & Kirby, B. (2013). Alchol and psoriasis: Sobering thoughts. Clinical Dermatology, 38(8), 819–822. https://doi.org/10.1111/ced.12013.CrossRef

Akay, A., Pekcanlar, A., Bozdag, K. E., Altintas, L., & Karaman, A. (2002). Assessment of depression in subjects with psoriasis vulgaris and lichen planus. Journal of European Academy of Dermatology and Venereology, 16, 347–352. https://doi.org/10.1046/j.1468-3083.2002.00467.x.CrossRef

Alpsoy, E., Polat, M., Fettahlioglu-Karaman, B., Karadag, A. S., Kartal-Durmazlar, P., Yalcin, B., … Senol, Y. (2017) Internalised stigma in psoriasis: A multicenter study. Journal of Dermatology, 44, 885–891. https://doi.org/10.1111/1346-8138.13841.CrossRef

Bagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994a). The twenty-item Toronto Alexithymia Scale-I. Item selection and cross-validation of the factor structure. Journal of Psychosomatic Research, 38, 23–32. https://doi.org/10.1016/0022-3999(94)90005-1.CrossRefPubMed

Bagby, R. M., Taylor, G. J., & Parker, J. D. A. (1994b). The twenty-item Toronto Alexithymia Scale-II. Convergent, discriminant and concurrent validity. Journal of Psychosomatic Research, 38, 33–40. https://doi.org/10.1016/0022-3999(94)90006-X.CrossRefPubMed

Bahmer, J., Kuhl, J., & Bahmer, F. A. (2007). How do personality systems interact in patients with psoriasis, atopic dermatitis and urticaria. Acta Dermato-Venerologica, 87, 317–324. https://doi.org/10.2340/00015555-0246.CrossRef

Bandura, A. (1997). Self-efficacy: The exercise of control. New York: W. H. Freeman.

Barry, R., Dudley, J., Tobin, A. M., O’ Brien, E., Rogers, S., Collins, P., & Kirby, B. (2005). The effects of alcohol intake and psychological distress on time to clearance of psoriasis treated with narrowband ultraviolet B. British Journal of Dermatology, 153, 43–44. https://doi.org/10.1111/j.1365-2133.2005.06628.x (Supplement Material).CrossRef

Basra, M. K., Fenech, R., Gatt, R. M., Salek, M. S., & Finlay, A. Y. (2008). The Dermatology Life Quality Index 1994–2007: A comprehensive review of validation data and clinical results. Birtish Journal of Dermatology, 159, 997–1035. https://doi.org/10.1111/j.1365-2133.2008.08832.x.CrossRef

Behar, E., Alcaine, O., Zuellig, A. R., & Borkovec, T. D. (2003). Screening for generalized anxiety disorder using the Penn State Worry Questionnaire: A receiver operating characteristic analysis. Journal of Behaviour Therapy and Experimental Psychiatry, 34, 25–43. https://doi.org/10.1016/S0005-7916(03)00004-1.CrossRef

Betka, S., Pfeifer, G., Garfinkel, S., Prins, H., Bond, R., Sequeira, H., … Critchley, H. (2018). How do self-assessment of alexithymia and sensitivity to bodily sensations relate to alcohol consumption? Alcoholism. Clinical and Experimental Research, 42, 81–88. https://doi.org/10.1111/acer.13542.CrossRef

Bilevicius, E., Single, A., Bristow, L. A., Foot, M., Ellery, M., Keough, M. T., & Johnson, E. A. (2018). Shame mediates the relationship between depression and addictive behaviours. Addictive Behaviours, 82, 94–100. https://doi.org/10.1016/j.addbeh.2018.02.023.CrossRef

Braathen, L. R., Botten, G., & Bjerkedal, T. (1989) Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Dermato-Venereologica, 142, 9–12.PubMed

Brenaut, E., Horreau, C., Pouplard, C., Barnetche, T., Paul, C., Richard, M. A., … Misery, L. (2013). Alcohol consumption and psoriasis: A systematic literature review. Journal of the European Academy of Dermatology and Venereology, 27(3), 30–35. https://doi.org/10.1111/jdv.12164.CrossRefPubMed

Buckner, J. D., & Heimberg, R. G. (2010). Drinking behaviours in social situations account for alcohol-related problems among socially anxious individuals. Psychology of Addictive Behaviours, 24, 640–648. https://doi.org/10.1037/a00209868.CrossRef

Burden, A. D., & Kirby, B. (2016). Psoriasis and related disorders. In C. Griffiths, J. Barker, T. Bleiker, C. Chalmers & D. Creamer (Eds.), Rook’s textbook of dermatology (9th ed., Vol. 2). Hoboken: Wiley-Blackwell.

Camisa, C. (2004). Handbook of psoriasis. Oxford: Blackwell Publishing.CrossRef

Cohen, B. E., Martires, K. J., & Ho, R. S. (2016). Psoriasis and the risk of depression in the US population: National health and nutrition examination survey 2009–2012. JAMA Dermatology, 152(1), 73–79. https://doi.org/10.1001/jamadermatol.2015.3605.CrossRefPubMed

Consoli, S. M., Rolhion, S., Martin, C., Ruel, K., Cambazard, F., Pellet, J., & Misery, L. (2006). Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis. Dermatology, 212, 128–136. https://doi.org/10.1159/000090653.CrossRefPubMed

Dalgard, F. J., Gieler, U., Tomas-Aragones, L., Lien, L., Poot, F., Jemec, G. B. E., … Kupfer, J. (2015). The psychological burden of skin diseases; a cross-sectional multicenter study among dermatological outpatients in 13 European countries. Journal of Investigative Dermatology. https://doi.org/10.1038/jid.2014.530.CrossRef

Devrimci-Ozguven, H., Kundakci, N., Kumbasar, H., & Boyvat, A. (2000). The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. Journal of the European Academy of Dermatology and Venereology, 14, 267–271. https://doi.org/10.1046/j.1468-3083.2000.00085.x.CrossRefPubMed

Dowlatshahi, E. A., Wakkee, M., Arends, L. R., & Nijsten, T. (2014). The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: A systematic review and meta-analysis. Journal of Investigative Dermatology, 136(6), 1542–1551. https://doi.org/10.1038/jid.2013.508.CrossRef

Esposito, M., Saraceno, R., Giunta, A., Maccarone, M., & Chimenti, S. (2006). An Italian study on psoriasis and depression. Dermatology, 212, 123–126. https://doi.org/10.1159/000090652.CrossRefPubMed

Fava, G. A., Perini, G. I., Santonastaso, P., & Formasa, C. V. (1980). Life events and psychological distress in dermatologic disorders: Psoriasis, chronic urticaria, and fungal infections. British Journal of Medical Psychology, 53, 277–282. https://doi.org/10.1111/j.2044-8341.1980.tb02551.x.CrossRef

Feldman, S. R., Fleischer, A. B., Reboussin, D. M., Rapp, S. R., Vanarthos, J. C., Exum, M. L., … Nurree, L. (1996). The self-administered psoriasis area and severity index is valid and reliable. Journal of Investigative Dermatology, 106, 183–186. https://doi.org/10.1111/1523-1747.ep12329912.CrossRef

Ferreira, B. R., Pio-Abreu, J. L., Reis, J. P., & Figueiredo, A. M. (2016). Psoriasis and associated psychiatric disorders: A systematic review on etiopathogenesis and clinical correlation. Journal of Clinical and Aesthetic Dermatology, 9(6), 36–43.

Ferreira, B. R., Pio-Abreu, J. L., Reis, J. P., & Figueiredo, A. M. (2017). Analysis of the prevalence of mental disorders in psoriasis: The relevance of psychiatric assessment in dermatology. Psychiatria Danubina, 29(4), 401–406. https://doi.org/10.24869/psyd.2017.401.CrossRefPubMed

Finlay, A. Y., & Coles, E. C. (1995). The effect of severe psoriasis on the quality of life of 369 patients. British Journal of Dermatology, 132, 236–244. https://doi.org/10.1111/j.1365-2133.1995.tb05019.x.CrossRef

Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Journal of Experimental Dermatology, 19, 210–216. https://doi.org/10.1111/j.1365-2230.1994.tb01167.x.CrossRef

Finzi, A., Colombo, D., Caputo, A., Andreassi, L., Chimenti, S., Vena, G., & Gianneti, A. (2007). Psychological distress an coping strategies in patients with psoriasis: The PSYCHAE study. European Academy of Dermatology and Venereology, 21, 1161–1169. https://doi.org/10.1111/j.1468-3083.2007.02079.x.CrossRef

Fleischer, A. B., Rapp, S. R., Reboussin, D. M., Varnathos, J. C., & Feldman, S. R. (1994). Patient measurement of psoriasis severity with a structured measurement. Journal of Investigative Dermatology, 102, 967–969. https://doi.org/10.1111/1523-1747.ep12384205.CrossRef

Fleming, P., Bai, J. W., Pratt, M., Sibbald, C., Lynde, C., & Gulliver, W. P. (2017). The prevalence of anxiety in patients with psoriasis: A systematic review of observational studies and clinical trials. Journal of the European Academy of Dermatology and Venereology, 31, 798–807. https://doi.org/10.1111/jdv.13891.CrossRefPubMed

Fleming, P., Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., … Gulliver, W. P. (2015). Effects of biologics on depressive symptoms in patients with psoriasis; a systematic review. Journal of the European Academy of Dermatology and Venereology, 29(6), 1063–1070. https://doi.org/10.1111/jdv.12909.CrossRefPubMed

Fortune, D. G., Main, C., O’Sullivan, T., & Griffiths, C. E. M. (1997). Assessing illness related stress in psoriasis: The psychometric properties of the Psoriasis Life Stress inventory. Journal of Psychosomatic Research, 42, 467–475. https://doi.org/10.1016/S0022-3999(97)00036-6.CrossRefPubMed

Fortune, D. G., Richards, H. L., & Griffiths, C. (2005a). Psychological factors in psoriasis: Consequences, mechanisms and interventions. Dermatology Clinics, 23, 681–694. https://doi.org/10.1016/j.det.2005.05.022.CrossRef

Fortune, D. L., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2002a). Psychological stress, distress and disability in patients with psoriasis: Consensus and variation in the contribution of illness perceptions, coping and alexithymia. British Journal of Clinical Psychology, 41, 157–174. https://doi.org/10.1348/014466502163949.CrossRef

Fortune, D. G., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2004). Targeting cognitive-behavioural therapy to patients’ implicit model of psoriasis: Results from a patient preference controlled trial. British Journal of Clinical Psychology, 43, 65–82. https://doi.org/10.1348/014466504772812977.CrossRef

Fortune, D. L., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2005b). Worry and pathological worry in patients with psoriasis: Cross sectional analyses of the Penn State Worry Questionnaire (PSWQ) in four samples of patients. Journal of Clinical Psychology in Medical Settings, 12, 143–152. https://doi.org/10.1007/s10880-005-3274-9.CrossRef

Fortune, D. L., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2005c). Adversarial growth in patients undergoing treatment for psoriasis: A prospective study of the ability of patients to construe benefits from negative events. Psychology, Health & Medicine, 10, 44–56. https://doi.org/10.1080/13548500512331315352.CrossRef

Fortune, D. G., Richards, H. L., Kirby, B., Bowcock, S., Main, C. J., & Griffiths, C. E. M. (2002c). A cognitive-behavioural symptom management as an adjunct in psoriasis therapy. British Journal of Dermatology, 146, 458–465. https://doi.org/10.1046/j.1365-2133.2002.04622.x.CrossRef

Fortune, D. G., Richards, H. L., Kirby, B., McElhone, K., Markham, T., Rogers, S., & Griffiths, C. E. M. (2003). Psychological distress impairs the rate of clearance of psoriasis in patients treated with photochemotherapy (PUVA). Archives of Dermatology, 139, 752–756. https://doi.org/10.1001/archderm.139.6.752.CrossRefPubMed

Fortune, D. L., Richards, H. L., Main, C. J., & Griffiths, C. E. M. (2000). Pathological worrying, illness perceptions and disease severity in patients with psoriasis. British Journal of Health Psychology, 5, 71–82. https://doi.org/10.1348/135910700168775.CrossRef

Fortune, D. L., Richards, H. L., Main, C. J., & Griffiths, C. E. M. (2002b). Patients’ strategies for coping with psoriasis. Clinical and Experimental Dermatology, 27, 177–184. https://doi.org/10.1046/j.1365-2230.2002.01055.CrossRefPubMed

Fortune, D. L., Richards, H. L., Main, C. J., O’Sullivan, T. M., & Griffiths, C. E. M. (1998). Developing clinical psychology services in an outpatient dermatology specialist clinic: What factors are associated with non-uptake of the service? Clinical Psychology Forum, 115, 34–36.

Fredriksson, T., & Pettersson, U. (1978). Severe psoriasis: Oral therapy with a new retinoid. Dermatologica, 157, 238–244.CrossRefPubMed

Gaston, L., Lassonde, M., Bernier-Buzzanga, J., Hodgins, S., & Crombez, J. C. (1987). Psoriasis and stress: A prospective study. Journal of American Academy of Dermatology, 17, 82–86. https://doi.org/10.1111/j.1468-3083.2008.02642.x.CrossRef

Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006). Risk of myocardial infarction in patients with psoriasis. JAMA, 296, 1735–1741.CrossRefPubMed

Gelfand, J. M., Weinstein, E., Porter, S. B., Neimann, A. L., Berlin, J. A., & Margolis, D. J. (2005). Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Archives of Dermatology, 141, 1537–1541.CrossRefPubMed

Ghorbani, F., Khosravani, V., Bastan, S. F., & Ardakani, J. A. (2017). The alexithymia, emotion regulation difficulties, positive and negative affects and suicidal risk in alcohol-dependent outpatients. Psychiatry Research, 252, 223–230. https://doi.org/10.1016/j.psychres.2017.03.005.CrossRefPubMed

Ginsburg, I. H., & Link, B. G. (1989). Feelings of stigmatization in patients with psoriasis. Journal of American Academy of Dermatology, 20, 53–63. https://doi.org/10.1016/S0190-9622(89)70007-4.CrossRef

Ginsburg, I. H., & Link, B. G. (1993). Psychosocial consequences of rejection and stigma feelings in psoriasis patients. International Journal of Dermatology, 32, 587–591. https://doi.org/10.1111/j.1365-4362.1993.tb05031.x.CrossRefPubMed

Golpour, M., Hosseini, S. H., Khademloo, M., Ghasemi, M., Ebadi, A., Koohkan, F., & Shahmohammadi, S. (2012). Depression and anxiety disorders among patients with psoriasis: A hospital-based case control study. Dermatology Research and Study. https://doi.org/10.1155/2012/381905.CrossRef

Gordon, K. B., Armstrong, A. W., Han, C., Foley, P., Song, M., Wasfi, Y., … Reich, K. (2018). Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab versus adalimumab: Results from the Phase 3 VOYAGE 2 study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.15012.CrossRefPubMed

Gupta, M. A., & Gupta, A. K. (1997). Psoriasis and sex: A study of moderately to severely affected patients. International Journal of Dermatology, 56, 259–262.CrossRef

Gupta, M. A., & Gupta, A. K. (1998). Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. British Journal of Dermatology, 139, 846–850. https://doi.org/10.1046/j.1365-2133.1998.02511.x.CrossRef

Gupta, M. A., & Gupta, A. K. (2003). Psychiatric and psychological co-morbidity in patients with dermatologic disorders: Epidemiology and management. American Journal of Clinical Dermatology, 4, 833–842.CrossRefPubMed

Gupta, M. A., Gupta, A. K., & Watteel, G. N. (1998). Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: An index of the stigma experience in dermatologic disorders. Cutis, 61, 339–342.PubMed

Gupta, M. A., Schork, N. J., Gupta, A. K., & Ellis, C. N. (1993). Alcohol intake and treatment responsiveness of psoriasis: A prospective study. Journal of the American Academy of Dermatology, 28, 730–732. https://doi.org/10.1016/0190-9622(93)70101-X.CrossRefPubMed

Hartka, E., Johnstone, B., Leino, V. E., Motoyoshp, M., Temple, M., & Fillmore, K. M. (1991). A meta-analysis of depressive symptomatology and alcohol consumption over time. British Journal of Addiction, 86, 1283–1298.CrossRefPubMed

Hermann, C. (1997). International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17–41. https://doi.org/10.1016/S0022-3999(96)00216-4.CrossRef

Hill, L., & Kennedy, P. (2002). The role of coping strategies in mediating subjective disability in people who have psoriasis. Psychology, Health and Medicine, 7, 261–267. https://doi.org/10.1080/13548500220139340.CrossRef

Hrehorow, E., Salomon, J., Matusiak, L., Reich, A., & Szepietowski, J. C. (2012). Patients with psoriasis feel stigmatised. Acta Dermato-Venereologica, 92, 67–72. https://doi.org/10.2340/00015555-1193.CrossRefPubMed

Hughes, J. E., Barraclough, L., Hamblin, G., & White, J. E. (1983). Psychiatric symptoms in dermatology patients. British Journal of Psychiatry, 143, 51–54. https://doi.org/10.1192/bjp.143.1.51.CrossRef

Innamorati, M., Quinto, R. M., Imperatori, C., Lora, V., Graceffa, D., Fabbricatore, M., … Bonifati, C. (2016). Health-related quality of life and its association with alexithymia and difficulties in emotion regulation in patients with psoriasis. Comprehensive Psychiatry, 70, 200–208. https://doi.org/10.1016/j.comppsych.2016.08.001.CrossRefPubMed

Janowski, K., Steuden, S., Pietzrak, A., Krasowska, D., Kacmarek, L., Gradus, I., & Chodorowska, G. (2012). Social support and adaptation to the disease in men and women in psoriasis. Archives of Dermatological Research, 304, 431–432. https://doi.org/10.1007/s00403-012-1235-3.CrossRef

Jensen, P., Ahlehoff, O., Egeberg, A., Gislason, G., Hansen, P. R., & Skov, L. (2016). Psoriasis and new-onset depression: A Danish nationwide cohort study. Acta Dermato-Venerologica, 96, 39–42. https://doi.org/10.2340/00015555-2183.CrossRef

Jowett, S., & Ryan, T. (1985). Skin disease and handicap: An analysis of the impact of skin conditions. Social Science and Medicine, 20, 425–429.CrossRefPubMed

Kauhanen, J., Kaplan, G. A., Julkunen, J., & Salonen, J. T. (1994). The association of alexithymia with all cause mortality: Prospective epidemiological evidence. Psychosomatic Medicine, 56, 149.CrossRef

Kent, G., & Keohane, S. (2001). Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experience. British Journal of Clinical Psychology, 40, 23–34.CrossRef

Kim, S. J., Park, M. Y., Pak, K., Han, J., Kim, G. W., Kim, H. S., … Kim, B. S. (2018). Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: An open label trial validated using beck depression inventory, Hamilton depression rating scale measures and ¹⁸fluorodeoxyglucose (FDG) positron emission tomography (PET). Journal of Dermatological Treatment, 7, 1–8. https://doi.org/10.1080/09546634.2018.1466021.CrossRef

Kimball, A. B., Jacobson, C., Weiss, S., Vreeland, M. G., & Wu, Y. (2005). The psychosocial burden of psoriasis. American International Journal of Dermatology, 6, 383–392.CrossRef

Kirby, B., Richards, H. L., Mason, D. L., Fortune, D. G., Main, C. J., & Griffiths, C. E. M. (2008). Alcohol consumption and psychological distress in patients with psoriasis. British Journal of Dermatology, 158, 138–140. https://doi.org/10.1111/j.1365-2133.2007.08299.x.CrossRef

Koo, J. (1996). Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatology Clinics, 14, 485–496. https://doi.org/10.1016/S0733-8635(05)70376-4.CrossRef

Korkoliakou, P., Christodoulou, C., Kouris, A., Porichi, P., Efstathiou, V., Kaloudi, E., … Douzenis, A. (2014). Alexithymia, anxiety and depression in patients with psoriasis: A case–control study. Annals of General Psychiatry, 13, 38. https://doi.org/10.1186/s12991-014-0038-7.CrossRefPubMedPubMedCentral

Korkoliakou, P., Efstathiou, V., Giannopoulou, I., Christodoulou, C., Kouris, A., Rigopoulos, D., & Douzenis, A. (2017). Psychopathology and alexithymia in patients with psoriasis. Anais Brazileiros De Dermatologia, 92(4), 510–515. https://doi.org/10.1590/abd1806-4841.20175660.CrossRef

Krueger, G., Koo, J., Lebwohl, M., Menter, A., Stern, R. S., & Rolstad, T. (2001). The impact of psoriasis on quality of life. Results of a 1198 national psoriasis foundation patient-membership survey. Archives of Dermatology, 137, 280–284.PubMed

Kurd, S. K., Troxel., A. B., Crits-Christoph, P., & Gelfand, J. M. (2010). The risk of depression, anxiety and suicidality in patients with psoriasis. Archives of Dermatology, 146, 891–895. https://doi.org/10.1001/archdermatol.2010.186.CrossRefPubMedPubMedCentral

Lakshmy, S., Balasundaram, S., Sarkar, S., Audhya, M., & Subramaniam, E. (2015). A cross-sectional study of prevalence and implications of depression and anxiety in psoriasis. Indian Journal of Psychological Medicine, 37(4), 434–440. https://doi.org/10.4103/0253-7176.168587.CrossRefPubMedPubMedCentral

Lakuta, P., Marcinkiewicz, K., Bergler-Czop, B., & Brzezinska-Wcislo, L. (2016). The relationship between psoriasis and depression: A multiple mediation model. Body Image, 19, 126–132. https://doi.org/10.1016/j.bodyim.2016.08.004.CrossRefPubMed

Lakuta, P., Marcinkiewicz, K., Bergler-Czop, B., Brzezinska-Wcislo, L., & Stomian, A. (2018). Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatisation in psoriasis patients. Advances in Dermatology and Allergology, 1, 60–66. https://doi.org/10.5114/pdia.2016.62287.CrossRef

Lamb, R. C., Matcham, M. A., Turner, M. A., Rayner, L., Simpson, A., Hotopf, M., … Smith, C. H. (2017). Screening for anxiety and depression in people with psoriasis: A cross sectional study in a tertiary referral setting. British Journal of Dermatology, 176, 1028–1034. https://doi.org/10.1111/bjd.14833.CrossRef

Lambert, J., Bostoen, J., Geusens, B., Bourgois, J., Boone, J., De Smedt, D., & Annemans, L. (2011). A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results. Archives of Dermatology Research, 303, 57–63. https://doi.org/10.1007/s00403-010-1082-z.CrossRef

Larsen, M. H., Krogstad, A. L., & Wahl, A. K. (2017). Alexithymia, illness perception and self-management competency in Psoriasis. Acta Dermato-Venereologica, 97(8), 934–940. https://doi.org/10.2340/00015555-2707.CrossRefPubMed

Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal and coping. New York: Springer.

Leary, M. R., Rapp, S. R., Herbst, K. C., Exum, M. L., & Feldman, S. R. (1998). Interpersonal concerns and psychological difficulties of psoriasis patients: Effects of disease severity and fear of negative evaluation. Health Psychology, 17, 530–536. https://doi.org/10.1037/0278-6133.17.6.530.CrossRefPubMed

Lesner, K., Reich, A., Szepietowski, J. C., Dalgard, F. J., Gieler, U., Tomas-Aragones, L., … Kupfer, J. (2017). Determinants of psychosocial health in psoriasis patients; a multinational study. Acta Dermato-Venereologica, 97(10), 1182–1188. https://doi.org/10.2340/00015555-2760.CrossRefPubMed

Leventhal, H., Leventhal, E. A., & Cameron, L. (2001). Representations, procedures, and affect in illness self-regulation: A perceptual-cognitive model. In A. Baum, T. A. Revenson & J. E. Singer (Eds.), Health psychology (pp. 19–47). New Jersey: Lawrence Erlbaum Associates.

Lindegard, B. (1986). Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica, 172, 298–304.CrossRefPubMed

Luminet, O., Cordovil de Sousa Uva, M., Fantini, C., & de Timary, P. (2016). The association between depression and craving in alcohol dependency is moderated by gender and by alexithymia factors. Psychiatry Research, 239, 28–38. https://doi.org/10.1016/j.psychres.2016.02.062.CrossRefPubMed

Luminet, O., Zech, E., Rime, B., & Wagner, H. (2000). Predicting cognitive and social consequences of emotional episodes: The contribution of emotional intensity, the five factor model and alexithymia. Journal of Research in Personality, 34, 471–497. https://doi.org/10.1006/jrpe.2000.2286.CrossRef

Maes, S., Leventhal, H., & de Ridder, D. T. D. (1996). Coping with chronic illness. In M. Zeidner, & N. S. Endler (Eds.), Handbook of coping: Theory, research, applications (pp. 221–252). New York: Willey.

McAleer, M. A., Mason, D. L., Cummingham, S., O’Shea, S. J., McCormick, P. A., Stone, C., & Kirby, B. (2011). Alcohol misuse in patients with psoriasis: Identification and relationship to disease severity and psychological distress. British Journal of Dermatology, 164, 1256–1261. https://doi.org/10.1111/j.1365-2133.2011.10345.x.CrossRef

McDonough, E., Ayearst, R., Eder, L., Chandran, V., Rosen, C. F., Thavaneswaran, A., & Gladman, D. D. (2014). Depression and anxiety in psoriatic disease: Prevalence and associated factors. Journal of Rheumatology, 41(5), 887–896. https://doi.org/10.3899/jrheum.130797.CrossRef

Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovek, T. D. (1990). Development and validation of the Penn State Worry Questionnaire. Behaviour Research Therapy, 28, 487–495.CrossRefPubMed

Mizara, A., Papadopoulos, L., & McBride, S. R. (2012). Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: The role of schemas in chronic skin disease. British Journal of Dermatology, 166(5), 986–993. https://doi.org/10.1111/j.1365-2133.2011.10799.x.CrossRef

Molina, S., & Borkovek, T. D. (1994). The Penn State Worry Questionnaire: Psychometric properties and associated characteristics. In G. G. L. Davey & F. Tallis (Eds.), Worrying: Perspectives on theory, assessment and treatment (pp. 265–283). Chichester: Wiley.

Nichol, M. B., Margolies, J. E., Lippa, E., Rowe, M., & Quell, J. (1996). The application of multiple quality of life instruments in individual with mild-to-moderate psoriasis. Pharmacoeconomics, 10, 644–653.CrossRefPubMed

Niemeier, V., Nippesen, M., Kupfer, J., Schill, W.-B., & Gieler, U. (2002). Psychological factors associated with hand dermatoses: Which subgroup needs psychological care? British Journal of Dermatology, 146, 1031–1037.CrossRef

Papadopoulos, L., & Walker, C. (2003). Understanding skin problems: Acne, eczema, psoriasis and related conditions. Chistester: Willey.

Parisi, R., Symmons, D. P., Griffiths, C. E., Ashcroft, D. M., & Identification and management of Psoriasis and Associated Comorbidity (IMPACT) Project Team. (2013). Global epidemiology of psoriasis: A systematic review of incidence and prevalence. Journal of Investigative Dermatology, 133, 377–385. https://doi.org/10.1038/jid.2012.339.CrossRef

Parker, G., & Brotchie, H. (2010). Gender differences in depression. International Review Psychiatry, 22, 429–436.CrossRef

Picardi, A., Abeni, D., Melchi, C. F., Puddu, P., & Pasquini, P. (2000). Psychiatric morbidity in dermatological outpatients: An issue to be recognized. British Journal of Dermatology, 143, 983–991. https://doi.org/10.1046/j.1365-2133.2000.03831.x.CrossRef

Picardi, A., Abeni, D., Renzi, C., Braga, M., Puddu, P., & Pasquini, P. (2001). Increased psychiatric morbidity in female outpatients with skin lesion on visible parts of the body. Acta Dermatolo-Venereologica, 81, 410–414. https://doi.org/10.1080/000155501317208345.CrossRef

Picardi, A., Mazzoti, E., Gaetano, P., Cattaruzza, M. S., Baliva, G., Melchi, C. F., & Pasquini, P. (2005). Stress, social support, emotional regulation and exacerbation of diffuse plaque psoriasis. Psychosomatics, 46, 556–564. https://doi.org/10.1176/appi.psy.46.6.556.CrossRefPubMed

Picardi, A., Mazzoti, E., & Pasquini, P. (2006). Prevalence and correlates of suicidal ideation among patients with skin disease. American Journal of Dermatology, 54, 420–426. https://doi.org/10.1016/j.jaad.2005.11.1103.CrossRef

Picardi, A., Pasquini, P., Cattaruzza, M. S., Gaetano, P., Baliva, G., Melchi, C. F., … Biondi, M. (2003a). Only limited support for a role of psychosomatic factors in psoriasis. Results from a case-control study. Journal of Psychosomatic Research, 55, 189–196. https://doi.org/10.1016/S0022-3999(02)00574-3.CrossRefPubMed

Picardi, A., Pasqioni, P., Cattaruzza, M. S., Gaetano, P., Melchi, C. F., Baliva, G., … Biondi, M. (2003b). Stressful life events, social support, attachment and alexithymia in vitiligo. Psychotherapy and Psychosomatics, 73, 150–158. https://doi.org/10.1159/000069731.CrossRef

Picardi, A., Porcelli, P., Mazzoti, E., Fassone, G., Lega, I., Ramieri, L., … Pasquini, P. (2007). Alexithymia and global psychosocial functioning: A study on patients with skin disease. Journal of Psychosomatic Research, 62, 223–229. https://doi.org/10.1016/j.jpsychores.2006.09.002.CrossRefPubMed

Pietrzak, A., Jastrzebaska, I., Chodorowska, G., Maciejewski, R., Mosiewicz, J., Krupski, W., & Herogova, J. (2011). Psoriasis and unreported excessive alcohol intake, a simple screening approach. Journal of European Dermatology and Venereology, 25, 1261–1268. https://doi.org/10.1111/j.1468-3083.2011.04101.x.CrossRef

Poikolainen, K., Reunala, T., & Karvonen, J. (1994). Smoking, alcohol and life events related to psoriasis among women. British Journal of Dermatology, 130, 437–477. https://doi.org/10.1111/j.1365-2133.1994.tb03380.x.CrossRef

Poikolainen, K., Reunala, T., Karvonen, J., Lauharanta, J., & Karkainen, P. (1990). Alcohol intake: A risk factor for young and middle aged men? British Medical Journal, 300, 780–783.CrossRefPubMedPubMedCentral

Pompili, M., Innamorati, M., Trovarelli, S., Narcisi, A., Bellini, S., Orsini, D., … Costanzo, A. (2016). Suicide risk and psychiatric comorbidity in patients with psoriasis. Journal of International Medical Research, 44(1), 61–66. https://doi.org/10.1177/0300060515593253.CrossRef

Porter, J. R., Beuf, A. H., & Lerner, A. (1986). Psychosocial effects of vitiligo: A comparison with ‘normal’ control subjects, with psoriasis patients, and with patients with other pigmentary disorders. Journal of American Academy of Dematology, 15, 220–224.CrossRef

Qureshi, A., Dominquez, P. L., Choi, H., Han, J., & Curhan, G. (2010). Alcohol intake and risk of incident psoriasis in US women: A prospective study. Archives of Dermatology, 146, 1364–1369. https://doi.org/10.1001/archdermatol.2010.204.CrossRefPubMedPubMedCentral

Ramsay, B., & O’Reagan, O. (1988). A survey of the social and psychological effects of psoriasis. British Journal of Dermatology, 118, 195–201. https://doi.org/10.1111/j.1365-2133.1988.tb01774.x.CrossRef

Rapp, S. R., Cottrell, C. A., & Leary, M. R. (2001). Coping strategies associated with quality of life decrements among psoriasis patients. British Journal of Dermatology, 145, 610–616. https://doi.org/10.1046/j.1365-2133.2001.04444.x.CrossRef

Rapp, S. R., Feldman, S. R., Exum, L., Fleischer, A. B., & Rebousin, D. M. (1999). Psoriasis causes as much disability as other major medical diseases. Journal of American Academy of Dermatology, 41, 401–407. https://doi.org/10.1016/S0190-9622(99)70112-x.CrossRef

Reinert, D. F., & Allen, J. P. (2007). The alcohol use disorders identification test: An update of research findings. Alcoholism: Clinical and Experimental Research, 31, 185–199. https://doi.org/10.1111/j.1530-0277.2006.00295.x.CrossRef

Renzi, C., Picardi, A., Abeni, D., Agostini, E., Baliva, G., Pasquini, P., & Braga, M. (2002). Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Archives of Dermatology, 138, 337–342.CrossRefPubMed

Richards, H. L., & Fortune, D. G. (2006). Psychological distress and adherence in patients with psoriasis. European Academy of Dermatology and Venereology, 20, 33–41. https://doi.org/10.1111/j.1468-3083.2006.01912.x.CrossRef

Richards, H. L., Fortune, D. G., Chong, S. L., Mason, D. L., Sweeney, S. K., Main, C. J., & Griffiths, C. E. (2004). Divergent beliefs about psoriasis are associated with increased psychological distress. Journal of Investigative Dermatology, 123, 49–56.CrossRef

Richards, H. L., Fortune, D. G., Griffiths, C. E. M., & Main, C. (2001). The contribution of perceptions of stigmatisation to disability in patients with psoriasis. Journal of Psychosomatic Research, 50, 11–15. https://doi.org/10.1016/S0022-3999(00)00210-5.CrossRefPubMed

Richards, H. L., Fortune, D. G., Griffiths, C. E. M., & Main, C. (2005). Alexithymia in patients with psoriasis: Clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. Journal of Psychosomatic Research, 58, 89–96. https://doi.org/10.1016/j.jpsychores.2004.03.009.CrossRefPubMed

Rodgers, B., Korten, A. E., Jorm, A. F., Jacomb, P. A., Christensen, H., & Henderson, A. S. (2000). Non-linear relationships in associations of depression and anxiety with alcohol use. Psychological Medicine, 30, 421–432.CrossRefPubMed

Root, S., Kent, G., & Al-Abadie, M. S. (1994). The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology, 189, 234–237. https://doi.org/10.1159/000246844.CrossRefPubMed

Russo, P. A., Ilchef, R., & Cooper, A. J. (2004). Psychiatric morbidity in psoriasis: A review. Australian Journal of Dermatology, 45, 155–159. https://doi.org/10.1111/j.1440-0960.2004.00078.x.CrossRef

Ryan, C., Sadlier, M., De Vol, E., Patel, M., Lloyd, A. A., Day, A., … Menter, A. (2015). Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. Journal of the American Academy of Dermatology, 72, 978–983. https://doi.org/10.1016/j.jaad.2015.02.1127.CrossRefPubMed

Sampogna, F., Chren, M. M., Melchi, C. F., Pasquini, P., Tabolli, S., Abeni, D., & The Italian Multipurpose Psoriasis Research on Vital Experiences (improve) Study Group. (2006). Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. British Journal of Dermatology, 154, 325–331. https://doi.org/10.1111/j.1365-2133.2005.06909.x.CrossRef

Sampogna, F., Puig, L., Spuls, P., Girolomoni, G., Radtke, M. A., Kirby, B., … EPIDEPSO Investigators. (2017). Prevalence of alexithymia in patients with psoriasis and its association with disease burden; a multicentre observational study. British Journal of Dermatology, 176(5), 1195–1203. https://doi.org/10.1111/bjd.15243.CrossRef

Sampogna, F., Tabolli, S., & Abeni, D. (2007). The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: A follow-up study. British Journal of Dermatology, 157, 508–513. https://doi.org/10.1111/j.1365-2133.2007.08071.x.CrossRef

Saunders, J. B., Aasland, O. G., Babor, T. F., De la Fuente, J. R., & Grant, M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO Collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction, 88, 791–804. https://doi.org/10.1111/j.1360-0443.1993.tb02093.x.CrossRefPubMed

Scharloo, M., Kaptein, A. A., Weinman, J., Bergman, W., Vermeer, B. J., & Rooijmans, H. G. M. (2000). Patients’ illness perceptions and coping as predictors of functional status in psoriasis: A 1-year follow up. British Journal of Dermatology, 142, 899–907. https://doi.org/10.1046/j.1365-2133.2000.03469.x.CrossRef

Schmid-Ott, G., Schallmayer, S., & Calliess, I. T. (2007). Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmatisation experience. Clinical Dermatology, 25, 547–554.CrossRef

Schmitt, J., & Ford, D. E. (2007a). Role of depression in quality of life for patients with psoriasis. Dermatology, 215, 17–25. https://doi.org/10.1159/000102029.CrossRefPubMed

Schmitt, J., & Ford, D. (2007b). Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis—a structural equations modelling approach. General Hospital Psychiatry, 29, 134–140. https://doi.org/10.1016/j.genhosppsych.2006.12.004.CrossRefPubMed

Schmitt, J., & Ford, D. E. (2010). Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. Journal of European Academy of Dermatology and Venereology, 24, 885–892. https://doi.org/10.1111/j.1468-3083.2009.03537.x.CrossRef

Singh, S., Taylor, C., Kornmehl, H., & Armstrong, A. W. (2017). Psoriasis and suicidality: A systematic review and meta-analysis. Journal of American Academy of Dermatology, 77(3), 425–440. https://doi.org/10.1016/j.jaad.2017.05.019.CrossRef

Smith, K. E., & Fenske, N. A. (2000). Cutaneous manifestations of alcohol abuse. Journal of American Academy of Dermatology, 43, 1–16. https://doi.org/10.1067/mjd.2000.104512.CrossRef

Taylor, G. J., Bagby, R. M., & Parker, J. D. A. (1997). Disorders of affect regulation: Alexithymia in medical and psychiatric illness. Cambridge: Cambridge University Press.CrossRef

Taylor, G. J., Bagby, R. M., & Parker, J. D. A. (2003). The 20-item Toronto Alexithymia Scale. IV. Reliability and factorial validity in different languages and cultures. Journal of Psychosomatic Research, 55, 277–283. https://doi.org/10.1016/S0022-3999(02)00578-0.CrossRefPubMed

Thompson, A. (2005). Coping with chronic skin conditions: Factors important in explaining individual variation in adjustment. In C. Walker & L. Papadopoulos (Eds.), Psychodermatology: The psychological impact of skin disorders (pp. 57–71). Cambridge: Cambridge University Press.

Tsai, T. F., Wang, T. S., Hung, S. T., Tsai, P. I. C., Schenkel, B., Zhang, M., & Tang, C. H. (2011). Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. Journal of Dermatology Science, 63, 40–46. https://doi.org/10.1016/j.j.dermsci.2011.03.002.CrossRef

Vladut, C. I., & Kallay, E. (2010). Psychosocial implications of psoriasis-theoretical review. Cognition, Brain, Behavior. An Interdisciplinary Journal, 14, 23–35.

Wahl, A. K., Gjengedal, E., & Hanestad, B. R. (2002). The bodily suffering of living with severe psoriasis: In depth interviews with 22 hospitalized patients with psoriasis. Qualitative Health Research, 12(2), 250–261. https://doi.org/10.1177/104973202129119874.CrossRefPubMed

Wojtuna, E., Lakuta, P., Marcinkiewicz, K., Bergler-Czop, B., & Brzezinska-Wcislo, L. (2017). Gender, body image and social support: Biopsychosocial determinants of depression among patients with psoriasis. Acta Dermato-Venereologica, 97, 91–97. https://doi.org/10.2340/00015555-2483.CrossRef

Wu, J. J., Feldman, R., Koo, J., & Marangell, B. (2017). Epidemiology of psoriasis. Journal of Dermatological Treatment, 10, 1–9. https://doi.org/10.1080/09546634.2017.1395800.CrossRef

Wu, S., Cho, E., Li, W. Q., Han, J., & Qureshi, A. A. (2015). Alcohol Intake and risk of psoriatic arthritis in women. Journal of Rheumatology, 42(5), 835–840. https://doi.org/10.3899/jrheum.140808.CrossRef

Yang, Y., Koh, D., Khoo, L., Nyunt, S. Z., Ng, V., & Goh, C. L. (2005). The psoriasis disability index in Chinese patients: Contribution of clinical and psychological variables. International Journal of Dermatology, 44, 925–929. https://doi.org/10.1111/j.1365-4632.2004.02237.x.CrossRefPubMed

Zachariae, R., Zachariae, H., Blomqvist, K., Davidsson, S., Molin, L., Mork, C., & Sigurgeirsson, B. (2004). Self reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. European Academy of Dermatology and Venereology, 18, 27–36. https://doi.org/10.1111/j.1468-3083.2004.00721.x.CrossRef

Zieciak, T., Rzepa, T., Krol, J., & Zaba, R. (2017). Feelings of stigmatization and depressive symptoms in psoriasis patients. Psychitria Polska, 51(6), 1153–1163. https://doi.org/10.12740/pp/68848.CrossRef

Zigmond, A. S., & Snaith, R. P. (1983). The Hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x.CrossRefPubMed

At a glance: The STEP trials

Springer Medicine

Psychological Distress, Alexithymia and Alcohol Misuse in Patients with Psoriasis: A Cross-Sectional Study

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2019

Feasibility of Including Behavioral Feeding Training Within a Parent Intervention for Young Children With Type 1 Diabetes

An Assessment of Medical Practitioners’ Knowledge of, Experience with, and Treatment Attitudes Towards Sleep Disorders and Nightmares

Identifying and Integrating Parent Priorities for Psychosocial Support Services in a Pediatric Cystic Fibrosis Clinic

Psychometric Properties of the Italian Perceived Maternal Parenting Self-Efficacy (PMP S-E)

Inflammatory Bowel Disease Patient Experiences with Psychotherapy in the Community

Behavioral Health Assessments and Interventions of Psychology Trainees and Residents During Dual Interviewing: Replication and Extension